IBM Sterling B2B Integrator up to 6.0.3.9/6.1.2.3/6.2.0.0 Web UI cross site scripting
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 4.4 | $0-$5k | 0.00 |
Summary
A vulnerability was found in IBM Sterling B2B Integrator up to 6.0.3.9/6.1.2.3/6.2.0.0. It has been declared as problematic. Affected by this issue is some unknown functionality of the component Web UI. The manipulation results in cross site scripting. This vulnerability was named CVE-2023-50307. The attack may be performed from remote. There is no available exploit. It is recommended to upgrade the affected component.
Details
A vulnerability was found in IBM Sterling B2B Integrator up to 6.0.3.9/6.1.2.3/6.2.0.0. It has been classified as problematic. Affected is some unknown processing of the component Web UI. The manipulation with an unknown input leads to a cross site scripting vulnerability. CWE is classifying the issue as CWE-79. The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users. This is going to have an impact on integrity. CVE summarizes:
IBM Sterling B2B Integrator 6.0.0.0 through 6.0.3.9, 6.1.0.0 through 6.1.2.3, and 6.2.0.0 is vulnerable to cross-site scripting. This vulnerability allows users to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session. IBM X-Force ID: 273338.
The advisory is shared for download at ibm.com. This vulnerability is traded as CVE-2023-50307 since 12/07/2023. The exploitability is told to be easy. It is possible to launch the attack remotely. Successful exploitation requires user interaction by the victim. There are neither technical details nor an exploit publicly available. The MITRE ATT&CK project declares the attack technique as T1059.007.
Upgrading eliminates this vulnerability.
The vulnerability is also documented in the vulnerability database at X-Force (273338). VulDB is the best source for vulnerability data and more expert information about this specific topic.
Product
Type
Vendor
Name
Version
- 6.0.3.0
- 6.0.3.1
- 6.0.3.2
- 6.0.3.3
- 6.0.3.4
- 6.0.3.5
- 6.0.3.6
- 6.0.3.7
- 6.0.3.8
- 6.0.3.9
- 6.1.2.0
- 6.1.2.1
- 6.1.2.2
- 6.1.2.3
- 6.2.0
License
Website
- Vendor: https://www.ibm.com/
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 4.4VulDB Meta Temp Score: 4.4
VulDB Base Score: 3.5
VulDB Temp Score: 3.4
VulDB Vector: 🔍
VulDB Reliability: 🔍
CNA Base Score: 5.4
CNA Vector (IBM Corporation): 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
Exploiting
Class: Cross site scriptingCWE: CWE-79 / CWE-94 / CWE-74
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: UpgradeStatus: 🔍
0-Day Time: 🔍
Timeline
12/07/2023 🔍04/12/2024 🔍
04/12/2024 🔍
04/06/2025 🔍
Sources
Vendor: ibm.comAdvisory: ibm.com
Status: Confirmed
CVE: CVE-2023-50307 (🔍)
GCVE (CVE): GCVE-0-2023-50307
GCVE (VulDB): GCVE-100-260448
X-Force: 273338
Entry
Created: 04/12/2024 06:10Updated: 04/06/2025 15:49
Changes: 04/12/2024 06:10 (66), 04/06/2025 15:49 (4)
Complete: 🔍
Cache ID: 216::103
VulDB is the best source for vulnerability data and more expert information about this specific topic.
No comments yet. Languages: en.
Please log in to comment.